Skip Navigation


Human Molecular Genetics Advance Access originally published online on February 17, 2009
Human Molecular Genetics 2009 18(8):1471-1481; doi:10.1093/hmg/ddp058
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
18/8/1471    most recent
ddp058v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Osborne, R. J.
Right arrow Articles by Thornton, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Osborne, R. J.
Right arrow Articles by Thornton, C. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy

Robert J. Osborne1,{dagger}, Xiaoyan Lin1, Stephen Welle2, Krzysztof Sobczak1, Jason R. O'Rourke3, Maurice S. Swanson3 and Charles A. Thornton1,*

1 Department of Neurology 2 Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA 3 Department of Molecular Genetics and Microbiology, Genetics Institute, University of Florida, College of Medicine, Gainesville, FL, USA

* To whom correspondence should be addressed at: Box 673 URMC, 601 Elmwood Avenue, Rochester, NY 14642. Tel: +1 5852752542; Fax: +1 5852731255; Email: charles_thornton{at}urmc.rochester.edu

Received December 1, 2008; Revised January 29, 2009; Accepted January 29, 2009

Myotonic dystrophy type 1 (DM1) is an RNA dominant disease in which mutant transcripts containing an expanded CUG repeat (CUGexp) cause muscle dysfunction by interfering with biogenesis of other mRNAs. The toxic effects of mutant RNA are mediated partly through sequestration of splicing regulator Muscleblind-like 1 (Mbnl1), a protein that binds to CUGexp RNA. A gene that is prominently affected encodes chloride channel 1 (Clcn1), resulting in hyperexcitability of muscle (myotonia). To identify DM1-affected genes and study mechanisms for dysregulation, we performed global mRNA profiling in transgenic mice that express CUGexp RNA, when compared with Mbnl1 knockout and Clcn1 null mice. We found that the majority of changes induced by CUGexp RNA in skeletal muscle can be explained by reduced activity of Mbnl1, including many changes that are secondary to myotonia. The pathway most affected comprises genes involved in calcium signaling and homeostasis. Some effects of CUGexp RNA on gene expression are caused by abnormal alternative splicing or downregulation of Mbnl1-interacting mRNAs. However, several of the most highly dysregulated genes showed altered transcription, as indicated by parallel changes of the corresponding pre-mRNAs. These results support the idea that trans-dominant effects of CUGexp RNA on gene expression in this transgenic model may occur at the level of transcription, RNA processing and mRNA decay, and are mediated mainly but not entirely through sequestration of Mbnl1.


{dagger} Present address: Population Genetics Technologies, Babraham Research Campus, Cambridge, CB22 3AT, UK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ScienceHome page
T. M. Wheeler, K. Sobczak, J. D. Lueck, R. J. Osborne, X. Lin, R. T. Dirksen, and C. A. Thornton
Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
Science, July 17, 2009; 325(5938): 336 - 339.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.